 Adam Terella
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 5 | 2021 | 847 | 1.180 |
Why?
| | Facial Neoplasms | 2 | 2019 | 19 | 1.170 |
Why?
| | Mohs Surgery | 4 | 2021 | 29 | 1.050 |
Why?
| | Forehead | 3 | 2019 | 5 | 0.910 |
Why?
| | Tissue Expansion | 2 | 2021 | 9 | 0.780 |
Why?
| | Dermatofibrosarcoma | 2 | 2019 | 7 | 0.740 |
Why?
| | Skull Base Neoplasms | 1 | 2022 | 30 | 0.710 |
Why?
| | Surgical Flaps | 3 | 2021 | 142 | 0.590 |
Why?
| | Cheek | 1 | 2019 | 16 | 0.580 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 21 | 0.570 |
Why?
| | Endoscopy | 3 | 2022 | 316 | 0.550 |
Why?
| | Postoperative Complications | 5 | 2022 | 2938 | 0.540 |
Why?
| | Skin | 1 | 2021 | 758 | 0.480 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 1148 | 0.390 |
Why?
| | Blepharoplasty | 1 | 2013 | 8 | 0.390 |
Why?
| | Eyelids | 1 | 2013 | 41 | 0.380 |
Why?
| | Eyebrows | 1 | 2012 | 2 | 0.380 |
Why?
| | Rhytidoplasty | 1 | 2012 | 2 | 0.380 |
Why?
| | Orbit | 1 | 2013 | 65 | 0.370 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2010 | 77 | 0.310 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 98 | 0.300 |
Why?
| | Skull | 1 | 2010 | 161 | 0.290 |
Why?
| | Osteogenesis | 1 | 2010 | 209 | 0.270 |
Why?
| | Polyethylene Glycols | 2 | 2010 | 655 | 0.270 |
Why?
| | Biopolymers | 1 | 2022 | 35 | 0.180 |
Why?
| | Chinchilla | 1 | 2022 | 35 | 0.180 |
Why?
| | Skull Base | 1 | 2022 | 54 | 0.180 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2022 | 71 | 0.170 |
Why?
| | Surgical Wound | 1 | 2021 | 27 | 0.170 |
Why?
| | Scalp | 1 | 2021 | 37 | 0.170 |
Why?
| | Perfusion | 1 | 2021 | 250 | 0.160 |
Why?
| | Sulfhydryl Compounds | 1 | 2022 | 189 | 0.160 |
Why?
| | Accessory Nerve Injuries | 1 | 2017 | 2 | 0.130 |
Why?
| | Wound Healing | 1 | 2020 | 351 | 0.130 |
Why?
| | Cranial Fossa, Anterior | 1 | 2017 | 2 | 0.130 |
Why?
| | Interferon-alpha | 3 | 2009 | 197 | 0.120 |
Why?
| | Arm | 1 | 2017 | 110 | 0.120 |
Why?
| | Bone Transplantation | 1 | 2017 | 87 | 0.120 |
Why?
| | Humans | 17 | 2022 | 145307 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 562 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2017 | 189 | 0.110 |
Why?
| | Antiviral Agents | 3 | 2009 | 768 | 0.110 |
Why?
| | Hepatitis C | 2 | 2009 | 254 | 0.100 |
Why?
| | Hematoma | 1 | 2013 | 59 | 0.090 |
Why?
| | Skin Aging | 1 | 2012 | 20 | 0.090 |
Why?
| | Rejuvenation | 1 | 2012 | 18 | 0.090 |
Why?
| | Liver Transplantation | 3 | 2004 | 827 | 0.090 |
Why?
| | Ribavirin | 2 | 2003 | 80 | 0.090 |
Why?
| | Corneal Injuries | 1 | 2013 | 42 | 0.090 |
Why?
| | Dry Eye Syndromes | 1 | 2013 | 56 | 0.090 |
Why?
| | Postoperative Hemorrhage | 1 | 2013 | 104 | 0.090 |
Why?
| | Hepatitis C, Chronic | 2 | 2004 | 152 | 0.090 |
Why?
| | Vision Disorders | 1 | 2013 | 178 | 0.080 |
Why?
| | Anhydrides | 1 | 2010 | 19 | 0.080 |
Why?
| | Norbornanes | 1 | 2010 | 15 | 0.080 |
Why?
| | Histiocytoma | 1 | 2009 | 2 | 0.080 |
Why?
| | Neurothekeoma | 1 | 2009 | 4 | 0.080 |
Why?
| | X-Ray Microtomography | 1 | 2010 | 107 | 0.080 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 20 | 0.080 |
Why?
| | Post-Exposure Prophylaxis | 1 | 2009 | 13 | 0.080 |
Why?
| | Photochemistry | 1 | 2010 | 134 | 0.080 |
Why?
| | Soft Tissue Neoplasms | 1 | 2009 | 127 | 0.070 |
Why?
| | Hepacivirus | 3 | 2009 | 243 | 0.070 |
Why?
| | Tissue Scaffolds | 1 | 2010 | 223 | 0.070 |
Why?
| | Retrospective Studies | 3 | 2022 | 17149 | 0.060 |
Why?
| | RNA, Viral | 3 | 2009 | 688 | 0.060 |
Why?
| | Animals | 3 | 2022 | 38180 | 0.060 |
Why?
| | Middle Aged | 6 | 2021 | 36021 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2541 | 0.050 |
Why?
| | Male | 8 | 2021 | 72629 | 0.050 |
Why?
| | Rats | 2 | 2010 | 5616 | 0.050 |
Why?
| | Health Personnel | 1 | 2009 | 748 | 0.050 |
Why?
| | Spatial Behavior | 1 | 2002 | 24 | 0.050 |
Why?
| | Retreatment | 1 | 2021 | 77 | 0.040 |
Why?
| | Preoperative Period | 1 | 2021 | 149 | 0.040 |
Why?
| | Multiple Trauma | 1 | 2002 | 121 | 0.040 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2004 | 373 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 542 | 0.040 |
Why?
| | Virus Replication | 1 | 2002 | 529 | 0.040 |
Why?
| | Liver Neoplasms | 1 | 2004 | 785 | 0.030 |
Why?
| | Motor Activity | 1 | 2002 | 725 | 0.030 |
Why?
| | Bone Regeneration | 1 | 2017 | 28 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 709 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2004 | 1243 | 0.030 |
Why?
| | Electromyography | 1 | 2017 | 416 | 0.030 |
Why?
| | Brain Concussion | 1 | 2002 | 640 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2009 | 1371 | 0.020 |
Why?
| | Viral Load | 2 | 2004 | 527 | 0.020 |
Why?
| | Mutation | 1 | 2002 | 4104 | 0.020 |
Why?
| | Cohort Studies | 2 | 2017 | 5982 | 0.020 |
Why?
| | Needlestick Injuries | 1 | 2009 | 3 | 0.020 |
Why?
| | Blood-Borne Pathogens | 1 | 2009 | 7 | 0.020 |
Why?
| | Female | 7 | 2017 | 78605 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2009 | 11731 | 0.020 |
Why?
| | Adult | 5 | 2017 | 40627 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5431 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2745 | 0.010 |
Why?
| | Occupational Exposure | 1 | 2009 | 354 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2009 | 1500 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1894 | 0.010 |
Why?
| | Prednisolone | 1 | 2003 | 66 | 0.010 |
Why?
| | Aspartate Aminotransferases | 1 | 2003 | 85 | 0.010 |
Why?
| | Swimming | 1 | 2002 | 50 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2002 | 94 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 2002 | 125 | 0.010 |
Why?
| | HIV | 1 | 2003 | 250 | 0.010 |
Why?
| | Random Allocation | 1 | 2002 | 363 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1386 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2004 | 1470 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 726 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2004 | 1540 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 392 | 0.010 |
Why?
| | Acute Disease | 1 | 2003 | 1031 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1138 | 0.010 |
Why?
| | Aged | 3 | 2004 | 26001 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2003 | 535 | 0.010 |
Why?
| | Base Sequence | 1 | 2002 | 2191 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 2158 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2003 | 847 | 0.010 |
Why?
| | Islets of Langerhans | 1 | 2004 | 841 | 0.010 |
Why?
| | Genetic Variation | 1 | 2002 | 986 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 2882 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 6079 | 0.010 |
Why?
| | Infant | 1 | 2009 | 10101 | 0.010 |
Why?
| | Child, Preschool | 1 | 2009 | 11863 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2004 | 5883 | 0.010 |
Why?
| | Child | 1 | 2009 | 22712 | 0.000 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2004 | 2592 | 0.000 |
Why?
| | Adolescent | 1 | 2004 | 22507 | 0.000 |
Why?
|
|
Terella's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|